Abstract
COVID-19 originates from a group of infections related to severe acute respiratory syndrome (SARS). Through data analysis, frameworks have demonstrated to have the option to approximate how patterns may progress. Data analysis assumes a key role, as does arithmetic, which, together with data science, permits us to have a top to bottom comprehension of the subtleties of nature and how things are made. As in the previous years, the pioneers of data science have had a mind-blowing effect on the reality where information and examination have been utilized to drive critical change throughout the spread of the sickness. One of the primary recorded uses of information examination was in 1852, during a cholera episode in London. John Snow, one of the primary information-driven disease transmission specialists, had the option to geospatially examine the passing that happened in London and in this manner segregate the wellspring of the infection. Depending on his investigation, specialists had the option to focus on their interventions to quickly check the spread of the pandemic. During this pandemic, information can be an exceptional factor as far as quality and consistency. Complexities of this sort incorporate instances of false-positive patients. Large data and data science can be utilized to check consistency with isolate and can be utilized for tranquilizing investigation. These are only a portion of the arrangements offered by new advanced innovations in the field of data science to confront the coronavirus crisis. We provide here early prediction and early survey, with the genuine and potential commitment of data science to the battle against COVID-19, just as the present requirements on these commitments. It expects to draw brisk take-away from a quick extending conversation and developing a collection of work, to fill in as a contribution for fast reactions in research, approach, and clinical examination. The expense of the pandemic as far as lives and monetary harm will be horrible; at the hour of composing, incredible vulnerability encompassed appraisals of exactly how awful and of how fruitful both non-pharmaceutical and pharmaceutical reactions can be. Improving data science, one of the most encouraging information expository apparatuses to have been created over the previous decade or something like that, to help decrease these vulnerabilities, is a beneficial interest. Data science isn’t yet assuming a huge job in the battle against COVID-19, at any rate from the epidemiological, demonstrative, and pharmaceutical perspectives. Its utilization is compelled by an absence of data and by an excess of noisy data. Enthusiastically, data analysts and researchers have responded to the challenge.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Khetrapal, S., Bhatia, R.: Impact of COVID-19 pandemic on health system & sustainable development goal 3. Indian J. Med. Res. 151, 395 (2020)
Surveillances, V.: The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020. China CDC Wkly. 2, 113–122 (2020)
World Health Organization. Pandemic influenza preparedness and response. World Health Organization. Accessed 23 Dec 2009 (2010)
Sujatha, R., Chatterjee, J.: A machine learning methodology for forecasting of the COVID-19 cases in India 2020. Stoch. Environ. Res. Risk Assess. 34, 959–972 (2020)
Yang, Z., Zeng, Z., Wang, K., Wong, S.-S., Liang, W., Zanin, M., et al.: Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions. J Thorac. Dis. 12, 165 (2020)
Sivarajah, U., Kamal, M.M., Irani, Z., Weerakkody, V.: Critical analysis of big data challenges and analytical methods. J. Bus. Res. 70, 263–286 (2017)
Feldman, B., Martin, E.M., Skotnes, T.: Big data in healthcare hype and hope. Dr. Bonnie. 360, 122–125 (2012)
Bellazzi, R.: Big data and biomedical informatics: a challenging opportunity. Yearb. Med. Inform. 23, 8–13 (2014)
Raghupathi, W., Raghupathi, V.: Big data analytics in healthcare: promise and potential. Heal. Inf. Sci. Syst. 2, 3 (2014)
Baro, E., Degoul, S., Beuscart, R., Chazard, E.: Toward a literature-driven definition of big data in healthcare. Biomed. Res. Int. 2015, 639021 (2015)
Manogaran, G., Thota, C., Lopez, D., Vijayakumar, V., Abbas, K.M., Sundarsekar, R.: Big data knowledge system in healthcare. In: Internet things big data technologies for next generation healthcare, pp. 133–157. Springer (2017)
Mezghani, E., Exposito, E., Drira, K., Da Silveira, M., Pruski, C.: A semantic big data platform for integrating heterogeneous wearable data in healthcare. J. Med. Syst. 39, 185 (2015)
Lin, K., Xia, F., Wang, W., Tian, D., Song, J.: System design for big data application in emotion-aware healthcare. IEEE Access. 4, 6901–6909 (2016)
Wang, C.J., Ng, C.Y., Brook, R.H.: Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing. J.A.M.A. 323, 1341–1342 (2020)
Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., et al.: Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc. Natl. Acad. Sci. U. S. A. 117, 9490–9496 (2020)
Zhou, C., Su, F., Pei, T., Zhang, A., Du, Y., Luo, B., et al.: COVID-19: challenges to GIS with big data. Geogr. Sustain. 1(1), 77–87 (2020)
Ienca, M., Vayena, E.: On the responsible use of digital data to tackle the COVID-19 pandemic. Nat. Med. 26, 463–464 (2020)
Desai, M.A.: Importance of AI & big data in the fight against coronavirus. Tathapi (UGC CARE J.). 19, 455–466 (2020) ISSN 2320-0693
Mayo, C.S., Matuszak, M.M., Schipper, M.J., Jolly, S., Hayman, J.A., Ten Haken, R.K.: Big data in designing clinical trials: opportunities and challenges. Front. Oncol. 7, 187 (2017)
Pocock, S.J., Hughes, M.D., Lee, R.J.: Statistical problems in the reporting of clinical trials. N. Engl. J. Med. 317, 426–432 (1987)
Yuan, J., Li, M., Lv, G., Lu, Z.K.: Monitoring transmissibility and mortality of COVID-19 in Europe. Int. J. Infect. Dis. 95, 311–315 (2020)
World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/emergencies/diseases/novelcoronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
Novel CPERE: The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 41, 145 (2020)
Rao, A.S.R.S., Vazquez, J.A.: Identification of COVID-19 can be quicker through artificial intelligence framework using a mobile phone–based survey when cities and towns are under quarantine. Infect. Control Hosp. Epidemiol. 41, 826–830 (2020)
Covid, C.D.C., Team, R.: Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12–March 16, 2020. MMWR Morb. Mortal. Wkly. Rep. 69, 343–346 (2020)
Daurat, A., Millet, I., Roustan, J.-P., Maury, C., Taourel, P., Jaber, S., et al.: Thoracic Trauma Severity score on admission allows to determine the risk of delayed ARDS in trauma patients with pulmonary contusion. Injury. 47, 147–153 (2016)
Latif, S., Usman, M., Manzoor, S., Iqbal, W., Qadir, J., Tyson, G., Castro, I., Razi, A., Boulos, M.N.K., Weller, A., Crowcroft, J.: Leveraging data science to combat COVID-19: a comprehensive review 2020. https://www.researchgate.net/publication/340687152_Preprint_Leveraging_Data_Science_To_Combat_COVID-19_A_Comprehensive_Review
Livingston, E., Bucher, K.: Coronavirus disease 2019 (COVID-19) in Italy. J.A.M.A. 323, 1335 (2020)
Rahimian, F., Salimi-Khorshidi, G., Payberah, A.H., Tran, J., Ayala Solares, R., Raimondi, F., et al.: Predicting the risk of emergency admission with machine learning: development and validation using linked electronic health records. PLoS Med. 15, e1002695 (2018)
Sohrabi, C., Alsafi, Z., O’Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., et al.: World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int. J. Surg. 76, 71–76 (2020)
Cockburn, I.M., Henderson, R.M.: Absorptive capacity, coauthoring behavior, and the organization of research in drug discovery. J. Ind. Econ. 46, 157–182 (1998)
Kubinyi, H.: 3D QSAR in drug design: volume 1: theory methods and applications, vol. 1. Springer (1993)
Murphy, R.F.: An active role for machine learning in drug development. Nat. Chem. Biol. 7, 327–330 (2011)
Li, L., Yang, Z., Dang, Z., Meng, C., Huang, J., Meng, H., et al.: Propagation analysis and prediction of the COVID-19. Infect. Dis. Model. 5, 282–292 (2020)
Abidi, S.S.R., Goh, A.: Applying knowledge discovery to predict infectious disease epidemics. In: Pacific Rim Int. Conf. Artif. Intell., pp. 170–181. Springer (1998)
Wynants, L., Van Calster, B., Bonten, M.M.J., Collins, G.S., Debray, T.P.A., De Vos, M., et al.: Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. B.M.J. 369 (2020)
Kraemer, M.U., Yang, C.H., Gutierrez, B., Wu, C.H., Klein, B., Pigott, D.M., Du Plessis, L., Faria, N.R., Li, R., Hanage, W.P.B.J.: The effect of human mobility and control measures on the COVID-19 epidemic in China. Science. 368, 493–497 (2020)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Tomar, P., Mann, M., Panwar, D., Diwaker, C., Kumar, P. (2021). Effectiveness of Big Data in Early Prediction and Measure for COVID-19 Using Data Science. In: Al-Turjman, F., Devi, A., Nayyar, A. (eds) Emerging Technologies for Battling Covid-19. Studies in Systems, Decision and Control, vol 324. Springer, Cham. https://doi.org/10.1007/978-3-030-60039-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-60039-6_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-60038-9
Online ISBN: 978-3-030-60039-6
eBook Packages: Computer ScienceComputer Science (R0)